Neoadjuvant Chemoimmunotherapy Cycle Number Selection for Non-Small Cell Lung Cancer and Clinical Outcomes: a Real-World Analysis
Frontiers in Oncology（2023）
Key words
non-small cell lung cancer,neoadjuvant chemoimmunotherapy,treatment cycles,adverse events,morbidity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined